Recall: D-0324-2021

Class II - Potentially Harmful

Class IIClassification

2021-03-31Initiated

OngoingStatus

Apotex Corp.Firm

Product

Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-3928-1, UPC 3 60505 39281 0

Reason

Cross Contamination with Other Product: Product is being recalled due to Trace Amounts of Quetiapine Fumarate

Distribution

Nationwide within the United States

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.